Global and China Chimeric Antigen Receptor Cell Therapy Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Chimeric Antigen Receptor Cell Therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Celyad SA

    • Novartis AG

    • Beijing Immunochina Medical Science & Technology Co Ltd

    • Bristol-Myers Squibb Co

    • Daiichi Sankyo Co Ltd

    • Nanjing Legend Biotech Co Ltd

    • Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

    • Gilead Sciences Inc

    • Hebei Senlang Biotechnology Inc Ltd

    • HRAIN Biotechnology Co Ltd

    • Sorrento Therapeutics Inc

    • Hangzhou Converd Co Ltd

    • Cellular Biomedicine Group Inc

    • CARsgen Therapeutics Ltd

    • bluebird bio Inc

    • Cell Medica Ltd

    • Celgene Corp

    • Nkarta Inc

    • Takara Bio Inc

    • Kite Pharma Inc

    • Autolus Therapeutics Plc

    • Bellicum Pharmaceuticals Inc

    • Celularity Inc

    • Guangzhou Anjie Biomedical Technology Co Ltd

    • Fosun Pharmaceutical AG

    • Amgen Inc

    • Ono Pharmaceutical Co Ltd

    • NantKwest Inc

    • Juno Therapeutics Inc

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Monotherapy

    • Combination Therapy

    Application:

    • Acute Leukemia

    • Non-hodgkin's Lymphoma

    • Multiple Myeloma

    • Transplant Rejection

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Chimeric Antigen Receptor Cell Therapy Industry Overview

      • 1.1.1 Chimeric Antigen Receptor Cell Therapy Market Scope and Market Segments

      • 1.1.2 Chimeric Antigen Receptor Cell Therapy Industry Characteristics

      • 1.1.3 Global and China Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Chimeric Antigen Receptor Cell Therapy Production Value and Growth Rate (2017-2028)

    • 1.2 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Monotherapy

      • 1.2.2 Combination Therapy

    • 1.3 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Acute Leukemia

      • 1.3.2 Non-hodgkin's Lymphoma

      • 1.3.3 Multiple Myeloma

      • 1.3.4 Transplant Rejection

      • 1.3.5 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Chimeric Antigen Receptor Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Chimeric Antigen Receptor Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Chimeric Antigen Receptor Cell Therapy Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Chimeric Antigen Receptor Cell Therapy Industry Porter's Five Forces Model Analysis

      • 2.2.3 Chimeric Antigen Receptor Cell Therapy Industry PEST Analysis

    • 2.3 Chimeric Antigen Receptor Cell Therapy Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Chimeric Antigen Receptor Cell Therapy Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Chimeric Antigen Receptor Cell Therapy Industry

    Chapter 3 Global and China Chimeric Antigen Receptor Cell Therapy Market, by Manufacturer

    • 3.1 Global and China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Chimeric Antigen Receptor Cell Therapy Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Chimeric Antigen Receptor Cell Therapy Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Chimeric Antigen Receptor Cell Therapy Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Chimeric Antigen Receptor Cell Therapy Market Top 3 Players

    Chapter 4 Global and China Chimeric Antigen Receptor Cell Therapy Market, by Type (2017-2028)

    • 4.1 Chimeric Antigen Receptor Cell Therapy Market Trend, by Type

    • 4.2 Global Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Chimeric Antigen Receptor Cell Therapy Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Chimeric Antigen Receptor Cell Therapy Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Chimeric Antigen Receptor Cell Therapy Price Trend, by Type (2017-2028)

    • 4.3 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Chimeric Antigen Receptor Cell Therapy Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Chimeric Antigen Receptor Cell Therapy Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Chimeric Antigen Receptor Cell Therapy Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Chimeric Antigen Receptor Cell Therapy Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Chimeric Antigen Receptor Cell Therapy Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Chimeric Antigen Receptor Cell Therapy Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Chimeric Antigen Receptor Cell Therapy Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Chimeric Antigen Receptor Cell Therapy Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Chimeric Antigen Receptor Cell Therapy Market Analysis

    • 7.1 North America Chimeric Antigen Receptor Cell Therapy Market, by Type

    • 7.2 North America Chimeric Antigen Receptor Cell Therapy Market, by Application

    • 7.3 North America Chimeric Antigen Receptor Cell Therapy Market Analysis and Forecast, by Country

      • 7.3.1 United States Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Chimeric Antigen Receptor Cell Therapy Market Analysis

    • 8.1 Europe Chimeric Antigen Receptor Cell Therapy Market, by Type

    • 8.2 Europe Chimeric Antigen Receptor Cell Therapy Market, by Application

    • 8.3 Europe Chimeric Antigen Receptor Cell Therapy Market Analysis and Forecast, by Country

      • 8.3.1 Germany Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Chimeric Antigen Receptor Cell Therapy Market Analysis

    • 9.1 APAC Chimeric Antigen Receptor Cell Therapy Market, by Type

    • 9.2 APAC Chimeric Antigen Receptor Cell Therapy Market, by Application

    • 9.3 APAC Chimeric Antigen Receptor Cell Therapy Market Analysis and Forecast, by Country

      • 9.3.1 China Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Analysis

    • 10.1 Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market, by Type

    • 10.2 Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market, by Application

    • 10.3 Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Chimeric Antigen Receptor Cell Therapy Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Chimeric Antigen Receptor Cell Therapy Company Profiles

      • 11.1 Celyad SA

        • 11.1.1 Celyad SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.1.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Novartis AG

        • 11.2.1 Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.2.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Beijing Immunochina Medical Science & Technology Co Ltd

        • 11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Bristol-Myers Squibb Co

        • 11.4.1 Bristol-Myers Squibb Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.4.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Daiichi Sankyo Co Ltd

        • 11.5.1 Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.5.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Nanjing Legend Biotech Co Ltd

        • 11.6.1 Nanjing Legend Biotech Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.6.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

        • 11.7.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.7.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Gilead Sciences Inc

        • 11.8.1 Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.8.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Hebei Senlang Biotechnology Inc Ltd

        • 11.9.1 Hebei Senlang Biotechnology Inc Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.9.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 HRAIN Biotechnology Co Ltd

        • 11.10.1 HRAIN Biotechnology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.10.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Sorrento Therapeutics Inc

        • 11.11.1 Sorrento Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.11.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Hangzhou Converd Co Ltd

        • 11.12.1 Hangzhou Converd Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.12.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Cellular Biomedicine Group Inc

        • 11.13.1 Cellular Biomedicine Group Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.13.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 CARsgen Therapeutics Ltd

        • 11.14.1 CARsgen Therapeutics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.14.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 bluebird bio Inc

        • 11.15.1 bluebird bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.15.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Cell Medica Ltd

        • 11.16.1 Cell Medica Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.16.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Celgene Corp

        • 11.17.1 Celgene Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.17.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Nkarta Inc

        • 11.18.1 Nkarta Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.18.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 Takara Bio Inc

        • 11.19.1 Takara Bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.19.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Kite Pharma Inc

        • 11.20.1 Kite Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.20.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Autolus Therapeutics Plc

        • 11.21.1 Autolus Therapeutics Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.21.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Bellicum Pharmaceuticals Inc

        • 11.22.1 Bellicum Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.22.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.23 Celularity Inc

        • 11.23.1 Celularity Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.23.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.23.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.24 Guangzhou Anjie Biomedical Technology Co Ltd

        • 11.24.1 Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.24.2 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.24.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.25 Fosun Pharmaceutical AG

        • 11.25.1 Fosun Pharmaceutical AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.25.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.25.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.26 Amgen Inc

        • 11.26.1 Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.26.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.26.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.27 Ono Pharmaceutical Co Ltd

        • 11.27.1 Ono Pharmaceutical Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.27.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.27.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.28 NantKwest Inc

        • 11.28.1 NantKwest Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.28.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.28.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.29 Juno Therapeutics Inc

        • 11.29.1 Juno Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.29.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Profiles, Application and Specification

        • 11.29.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Chimeric Antigen Receptor Cell Therapy Industry Investment Prospect and Risk Assessment

    • 12.1 Chimeric Antigen Receptor Cell Therapy Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Chimeric Antigen Receptor Cell Therapy Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Production Value and Growth Rate (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Production Value and Growth Rate (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Monotherapy (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Combination Therapy (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Acute Leukemia (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Non-hodgkin's Lymphoma (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Multiple Myeloma (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Transplant Rejection (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Chimeric Antigen Receptor Cell Therapy Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Chimeric Antigen Receptor Cell Therapy Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Chimeric Antigen Receptor Cell Therapy Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Chimeric Antigen Receptor Cell Therapy Market Share, by Manufacturer in 2021

    • Figure Global and China Chimeric Antigen Receptor Cell Therapy Market Share, by Manufacturer in 2022

    • Table Global Chimeric Antigen Receptor Cell Therapy Sales Volume, by Type (2017-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Sales Value, by Type (2017-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Sales Value Share, by Type (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Price Trend, by Type (2017-2028)

    • Table China Chimeric Antigen Receptor Cell Therapy Sales Volume, by Type (2017-2028)

    • Table China Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table China Chimeric Antigen Receptor Cell Therapy Sales Value, by Type (2017-2028)

    • Table China Chimeric Antigen Receptor Cell Therapy Sales Value Share, by Type (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Price Trend, by Type (2017-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Sales Volume, by Application (2017-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Sales Value, by Application (2017-2028)

    • Table Global Chimeric Antigen Receptor Cell Therapy Sales Value Share, by Application (2017-2028)

    • Figure Global Chimeric Antigen Receptor Cell Therapy Sales Value Share, by Application (2017-2028)

    • Table China Chimeric Antigen Receptor Cell Therapy Sales Volume, by Application (2017-2028)

    • Table China Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Table China Chimeric Antigen Receptor Cell Therapy Sales Value, by Application (2017-2028)

    • Table China Chimeric Antigen Receptor Cell Therapy Sales Value Share, by Application (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Sales Value Share, by Application (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure North America Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export (2017-2022)

    • Table North America Chimeric Antigen Receptor Cell Therapy Sales Volume, by Type (2017-2028)

    • Table North America Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure North America Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table North America Chimeric Antigen Receptor Cell Therapy Sales Volume, by Application (2017-2028)

    • Table North America Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure North America Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure United States Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure United States Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Canada Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Table Europe Chimeric Antigen Receptor Cell Therapy Sales Volume, by Type (2017-2028)

    • Table Europe Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Europe Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table Europe Chimeric Antigen Receptor Cell Therapy Sales Volume, by Application (2017-2028)

    • Table Europe Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Europe Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Germany Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure UK Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure UK Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure France Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure France Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Italy Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Spain Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Poland Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Russia Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Table APAC Chimeric Antigen Receptor Cell Therapy Sales Volume, by Type (2017-2028)

    • Table APAC Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure APAC Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table APAC Chimeric Antigen Receptor Cell Therapy Sales Volume, by Application (2017-2028)

    • Table APAC Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure APAC Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure China Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Japan Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure India Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure India Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Chimeric Antigen Receptor Cell Therapy Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Chimeric Antigen Receptor Cell Therapy Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Chimeric Antigen Receptor Cell Therapy Sales Value and Growth Rate (2017-2028)

    • Table Celyad SA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celyad SA Product Profiles, Application and Specification

    • Table Celyad SA Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG Product Profiles, Application and Specification

    • Table Novartis AG Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Beijing Immunochina Medical Science & Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Beijing Immunochina Medical Science & Technology Co Ltd Product Profiles, Application and Specification

    • Table Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb Co Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daiichi Sankyo Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daiichi Sankyo Co Ltd Product Profiles, Application and Specification

    • Table Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nanjing Legend Biotech Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nanjing Legend Biotech Co Ltd Product Profiles, Application and Specification

    • Table Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Product Profiles, Application and Specification

    • Table Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gilead Sciences Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gilead Sciences Inc Product Profiles, Application and Specification

    • Table Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hebei Senlang Biotechnology Inc Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hebei Senlang Biotechnology Inc Ltd Product Profiles, Application and Specification

    • Table Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table HRAIN Biotechnology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table HRAIN Biotechnology Co Ltd Product Profiles, Application and Specification

    • Table HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sorrento Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sorrento Therapeutics Inc Product Profiles, Application and Specification

    • Table Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hangzhou Converd Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hangzhou Converd Co Ltd Product Profiles, Application and Specification

    • Table Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cellular Biomedicine Group Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cellular Biomedicine Group Inc Product Profiles, Application and Specification

    • Table Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CARsgen Therapeutics Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CARsgen Therapeutics Ltd Product Profiles, Application and Specification

    • Table CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table bluebird bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table bluebird bio Inc Product Profiles, Application and Specification

    • Table bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cell Medica Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cell Medica Ltd Product Profiles, Application and Specification

    • Table Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celgene Corp Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celgene Corp Product Profiles, Application and Specification

    • Table Celgene Corp Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nkarta Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nkarta Inc Product Profiles, Application and Specification

    • Table Nkarta Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takara Bio Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takara Bio Inc Product Profiles, Application and Specification

    • Table Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kite Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kite Pharma Inc Product Profiles, Application and Specification

    • Table Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Autolus Therapeutics Plc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Autolus Therapeutics Plc Product Profiles, Application and Specification

    • Table Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bellicum Pharmaceuticals Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bellicum Pharmaceuticals Inc Product Profiles, Application and Specification

    • Table Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Celularity Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Celularity Inc Product Profiles, Application and Specification

    • Table Celularity Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Guangzhou Anjie Biomedical Technology Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Guangzhou Anjie Biomedical Technology Co Ltd Product Profiles, Application and Specification

    • Table Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fosun Pharmaceutical AG Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fosun Pharmaceutical AG Product Profiles, Application and Specification

    • Table Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Inc Product Profiles, Application and Specification

    • Table Amgen Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ono Pharmaceutical Co Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ono Pharmaceutical Co Ltd Product Profiles, Application and Specification

    • Table Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NantKwest Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NantKwest Inc Product Profiles, Application and Specification

    • Table NantKwest Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Juno Therapeutics Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Juno Therapeutics Inc Product Profiles, Application and Specification

    • Table Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.